Noida

NEEDS PHARMA, We would like to introduce ourselves a WHO - GMP certified manufacturing unit from INDIA willing to turn the milestone in Pharmaceutical era.
We manufacture Tablets, Capsule, Syrups, Suspensions and other formulations and are exporting to various countries across the Globe.

About Authors:
Das Saumya¹*, Basu saumya Priya¹, Das Manas Kumar², Das Sanjita¹
1. Institute of Pharmaceutical Technology, NIET, Greater Noida, U.P., India.
2. Department of Pharmacy,
IEC-CET,
Greater Noida, U.P.,
India.

Introduction
Cancer has been one of the greatest scourges of mankind since time immemorial. It may be regarded as a series of malignant diseases characterized by (i) abnormal growth of cells (ii) ability to invade adjacent tissues and even distant organs and (iii) the eventual death of the affected patient if the tumor has progressed beyond the stage where it can be successfully removed. The incidence of cancer is expected to rise worldwide notably because of increase in life expectancy, changes in lifestyle patterns and environmental factors. Over the years, an increased understanding of cancer at cellular, molecular and genetic levels is opening up enormous opportunities to interrupt its initiation and progression. Although rapid strides have been made in treatment of cancer, there still remain many stumbling blocks in achieving cancer prevention and cure.

JIIT has been developed as a modern world class campus, with intellectually vibrant ambience in a serene and lush green environment. The state-of-the-art campus at a total project cost of Rs. 162 cores, with a total built up area of over 69623 sq.

The growing Indian market for Schwabe products necessitated to establish a manufacturing facility in India with the aim to provide standard quality products at affordable Indian price. Schwabe remedies had a long tradition in India. Homoeopaths in India have used and continue to use Schwabe formulations based on their deep faith in the quality of its medicines. In fact our first order from India was raised over a century back.

Ajanta Pharma Limited is an emerging, global pharmaceutical company with proven capabilities in the areas of product research, manufacturing & marketing.

This time people performed well. looks like approved than previous tests. Passing marks was 40 % and so many of the candidates reach there to pass. Let me remind you there was no negative marks system otherwise it can affect your result. But anyways overall it was nice performance.

That was real traffic of candidates on GPAT-TUTOR Platform for OCF 2011's test-2. The no. of candidates participating in OCF competition is increased for TEST-2. The test was much easier than test -1 and passing percentage was 50 % ... But Let me tell you very few of you cross that margin. But don’t worry as in GPAT if you would score atleast 35-40 %, you can qualify the pharma giant entrance.